July 2026
1. WATSON MC, Neil KE
   Mandatory, standardised food labelling should be just one element of a multifaceted campaign against obesity.
   BMJ. 2026;394:e100354.
   

   >> Share

   
   
2. GASOYAN H, Rothberg MB
   Comparing benefits and harms of obesity drugs.
   BMJ. 2026;394:e725349.
   

   >> Share

   
   
3. NONG K, Shi Q, Xie X, Wang Y, et al
   Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.
   BMJ. 2026;394:e372161.
   

   >> Share

   
   
4. TORJESEN I
   Most obesity drugs do not improve quality of life or reduce cardiovascular risk, analysis finds.
   BMJ. 2026;394:e100232.
   

   >> Share

   
   June 2026
5. WISE J
   Obesity is rising fastest in young adults, study shows.
   BMJ. 2026;393:e100097.
   

   >> Share

   
   
6. MURPHY F
   Obesity versus China: how Ozempic is complicating the world's largest weight loss campaign.
   BMJ. 2026;393:e523232.
   

   >> Share

   
   
7. VOGEL C
   A single, mandatory warning label on unhealthy foods is key to a joined-up approach to obesity.
   BMJ. 2026;393:e288249.
   

   >> Share

   
   May 2026
8. MAHASE E
   Obesity, weight loss drugs, and art: why Picasso would have painted "GLP-1 face".
   BMJ. 2026;393:e515080.
   

   >> Share

   
   April 2026
9. KOPITOWSKI K, Franco JVA
   Weight "regain" in obesity shifts responsibility from biology to personal inadequacy.
   BMJ. 2026;393:s648.
   

   >> Share

   
   March 2026
10. BUSE K, Carriedo A, Barquera S
    Treatment with GLP-1 drugs must not replace obesity prevention in low and middle income countries.
    BMJ. 2026;392:s407.
    

    >> Share

    
    February 2026
11. WISE J
    Obesity: One in 10 infectious disease deaths linked to condition, study shows.
    BMJ. 2026;392:s263.
    

    >> Share

    
    January 2026
12. WILKINSON E
    Child obesity: McDonald's drive-through plan rejected by Sheffield Council on health grounds.
    BMJ. 2026;392:s130.
    

    >> Share

    
    
13. WEST S, Scragg J, Aveyard P, Oke JL, et al
    Weight regain after cessation of medication for weight management: systematic review and meta-analysis.
    BMJ. 2026;392:e085304.
    

    >> Share

    
    
14. FALLOWS E
    Effective obesity care? Doctors could ask more about people's lives and less about their weight.
    BMJ. 2026;392:s1.
    

    >> Share

    
    
15. DYER O
    Pill version of obesity jab is approved in US, with UK decision pending.
    BMJ. 2026;392:s2.
    

    >> Share

    
    December 2025
16. SMUTNA T
    Government plans to tackle childhood obesity must follow Unicef's guidance.
    BMJ. 2025;391:r2542.
    

    >> Share

    
    
17. TAYLOR L
    Obesity: WHO calls for increased production of Ozempic and other weight loss drugs.
    BMJ. 2025;391:r2540.
    

    >> Share

    
    
18. MULVIHILL C, Parretti HM, Aswani N
    Overweight and obesity management: summary of updated NICE guidance.
    BMJ. 2025;391:r2286.
    

    >> Share

    
    November 2025
19. LOGAN M
    Trump expands visa requirements to include diabetes and obesity.
    BMJ. 2025;391:r2400.
    

    >> Share

    
    
20. BROWN C
    Trump strikes deal with Ozempic and Mounjaro makers to cut prices of obesity injections.
    BMJ. 2025;391:r2361.
    

    >> Share

    
    
21. WISE J
    Obesity levels in schoolchildren at highest level outside pandemic.
    BMJ. 2025;391:r2346.
    

    >> Share

    
    October 2025
22. COHEN JFW, Chapman LE, Schwartz MB
    The implications of the Make Our Children Healthy Again report for child health and obesity in the US.
    BMJ. 2025;391:r2116.
    

    >> Share

    
    
23. NOLAN T
    Low dose oral semaglutide for obesity . . . and other research.
    BMJ. 2025;391:r2050.
    

    >> Share

    
    September 2025
24. 
    BMJ reports on the food industry, obesity services, and doctor suicide honoured at prestigious awards.
    BMJ. 2025;390:r1966.
    

    >> Share

    
    
25. IACOBUCCI G
    Childhood obesity more common than underweight for first time in history, Unicef reports.
    BMJ. 2025;390:r1915.
    

    >> Share

    
    
26. MAHASE E
    Energy drinks ban: Experts welcome government action for under 16s but question obesity claims.
    BMJ. 2025;390:r1862.
    

    >> Share

    
    August 2025
27. BOWIE K
    Industry funded NHS obesity programme raises "significant" conflict of interest concerns.
    BMJ. 2025;390:r1793.
    

    >> Share

    
    
28. LI B, Wetzel M, Ogweno S, Buse K, et al
    Neglecting obesity in the 2025 NCD agenda will leave one billion people behind.
    BMJ. 2025;390:r1693.
    

    >> Share

    
    July 2025
29. ANSELMI ME, Ralston J, Axelrod S
    Obesity in Latin America: effective responses value lived experience.
    BMJ. 2025;390:r1211.
    

    >> Share

    
    
30. HAGENAARS LL, Bero LA, van der Voorn B, Schmidt LA, et al
    Caution is prescribed for American Academy of Paediatrics' guidelines on weight loss medications for childhood obesity.
    BMJ. 2025;390:e084760.
    

    >> Share

    
    June 2025
31. WISE J
    Obesity plan puts onus on supermarkets to promote healthy food.
    BMJ. 2025;389:r1361.
    

    >> Share

    
    
32. RADA AG
    Spanish officials investigate Novo Nordisk's obesity awareness campaign.
    BMJ. 2025;389:r1319.
    

    >> Share

    
    May 2025
33. MAHASE E
    New NHS obesity service to provide access to weight loss injections in Northern Ireland.
    BMJ. 2025;389:r1069.
    

    >> Share

    
    
34. DELGADO C
    Obesity: can we cure our dependence on BMI?
    BMJ. 2025;389:r241.
    

    >> Share

    
    
35. MOSCROP A, Dorling D, Cole TJ, Wright C, et al
    Child height figures show effects of covid, obesity, and inequality.
    BMJ. 2025;389:r917.
    

    >> Share

    
    April 2025
36. MAHASE E
    Obesity: Concerns are raised over food industry's influence on government advisory board.
    BMJ. 2025;389:r674.
    

    >> Share

    
    
37. OMENI-NZEWUIHE CC
    Tackling obesity: government must learn from failures in tobacco control.
    BMJ. 2025;389:r649.
    

    >> Share

    
    March 2025
38. MYTTON OT, Campbell-Scherer D, Reckless I, Llewellyn C, et al
    Diagnosing and defining obesity.
    BMJ. 2025;388:r460.
    

    >> Share

    
    
39. HUSE O, Sethi V, Rowel D, Shahula Ahmed A, et al
    Home, school, and retail food environments driving obesity among adolescent girls in South Asia.
    BMJ. 2025;388:e080359.
    

    >> Share

    
    February 2025
40. O'DOWD A
    Wales to crack down on junk food promotions to tackle obesity.
    BMJ. 2025;388:r316.
    

    >> Share

    
    
41. CARRON M, Tamburini E
    High flow nasal oxygenation in sedated gastrointestinal endoscopy for patients with obesity.
    BMJ. 2025;388:r184.
    

    >> Share

    
    
42. WANG L, Zhang Y, Han D, Wei M, et al
    Effect of high flow nasal cannula oxygenation on incidence of hypoxia during sedated gastrointestinal endoscopy in patients with obesity: multicentre randomised controlled trial.
    BMJ. 2025;388:e080795.
    

    >> Share

    
    January 2025
43. MAHASE E
    Obesity: Government accused of kicking problem "into the long grass" despite growing crisis.
    BMJ. 2025;388:r229.
    

    >> Share

    
    
44. MAHASE E
    Obesity: Doctors should use "clinical judgment" to intervene if concerned about a child, NICE says.
    BMJ. 2025;388:r162.
    

    >> Share

    
    
45. LANG K
    Can weight loss drugs like Ozempic treat obesity in children?
    BMJ. 2025;388:q2656.
    

    >> Share

    
    
46. WATSON MC, Towers A
    Childhood obesity: positive change is possible.
    BMJ. 2025;388:r80.
    

    >> Share

    
    
47. IACOBUCCI G
    Define obesity as clinical or pre-clinical for more accurate diagnosis, says global commission.
    BMJ. 2025;388:r78.
    

    >> Share

    
    December 2024
48. FRANCO JVA, Manne-Goehler J
    GLP-1 receptor agonists and obesity care.
    BMJ. 2024;387:q2732.
    

    >> Share

    
    
49. WISE J
    Tirzepatide: Obesity injection will get phased rollout to avoid overwhelming GPs.
    BMJ. 2024;387:q2744.
    

    >> Share

    
    November 2024
50. IACOBUCCI G
    Childhood obesity in England's most deprived areas is double that in affluent areas.
    BMJ. 2024;387:q2457.
    

    >> Share

    
    October 2024
51. WISE J
    Obesity: Peers call for total ban on junk food advertising.
    BMJ. 2024;387:q2329.
    

    >> Share

    
    
52. LIMB M
    NHS England consults on rolling out obesity injection tirzepatide to meet demand.
    BMJ. 2024;387:q2180.
    

    >> Share

    
    September 2024
53. IACOBUCCI G
    Junk food TV adverts to be banned before 9 pm to tackle childhood obesity.
    BMJ. 2024;386:q2006.
    

    >> Share

    
    
54. MAHASE E
    Liraglutide: Weight loss injection is effective in children aged 6-11, study reports.
    BMJ. 2024;386:q1998.
    

    >> Share

    
    
55. MAHASE E
    Obesity: Only half of England has access to comprehensive weight loss services.
    BMJ. 2024;386:q1950.
    

    >> Share

    
    
56. MCLAUGHLIN J, Rejon CS, Bell M, Schwander B, et al
    Holistic modelling as a catalyst for effective obesity policy.
    BMJ. 2024;386:e077139.
    

    >> Share

    
    
57. HOPTION CANN SA
    Tackling unhealthy food and obesity: teach children so they can teach their families.
    BMJ. 2024;386:q1925.
    

    >> Share

    
    August 2024
58. GUENOT M
    How do GLP-1 drugs work for weight loss . . . and everything else?
    BMJ. 2024;386:q1767.
    

    >> Share

    
    July 2024
59. BRIGGS A, Everest G
    Tackling unhealthy food and obesity: how far will the new Labour government go?
    BMJ. 2024;386:q1707.
    

    >> Share

    
    
60. HAZLEHURST JM
    Obesity: time for NHS England to step up.
    BMJ. 2024;386:q1643.
    

    >> Share

    
    
61. SALISBURY H
    Helen Salisbury: Weight loss treatment-available in theory but not in practice.
    BMJ. 2024;386:q1626.
    

    >> Share

    
    
62. NOLAN T
    How do tirzepatide and semaglutide compare for weight loss ... and other research.
    BMJ. 2024;386:q1564.
    

    >> Share

    
    June 2024
63. MAHASE E
    Obesity: Integrated care boards close lists for weight management services as demand skyrockets.
    BMJ. 2024;385:q1356.
    

    >> Share

    
    
64. BUSE K, McKee M
    Obesity-a vital issue that's being overlooked in the UK elections.
    BMJ. 2024;385:q1378.
    

    >> Share

    
    
65. WILKINSON E
    NICE recommendations on tirzepatide for weight loss could increase NHS access.
    BMJ. 2024;385:q1239.
    

    >> Share

    
    May 2024
66. MAHASE E
    Semaglutide may provide sustained weight loss for at least four years, study reports.
    BMJ. 2024;385:q1113.
    

    >> Share

    
    April 2024
67. WISE J
    NHS weight loss programme produces moderate benefit, analysis shows.
    BMJ. 2024;385:q930.
    

    >> Share

    
    
68. PRATSIDES L
    The merits of an integrated approach to obesity treatment and prevention.
    BMJ. 2024;385:q822.
    

    >> Share

    
    March 2024
69. HENDERSON K, Lewis, Sloan CE, Bessesen DH, et al
    Effectiveness and safety of drugs for obesity.
    BMJ. 2024;384:e072686.
    

    >> Share

    
    
70. KOLKER C
    Chile passed tough measures to combat an obesity epidemic, so why does it still have an obesity problem?
    BMJ. 2024;384:q584.
    

    >> Share

    
    
71. BUSE K, Ralston J, Barquera S
    Let's talk differently about obesity.
    BMJ. 2024;384:q537.
    

    >> Share

    
    
72. TAYLOR L
    One in eight people globally are obese, with rates in children increasing fourfold in three decades.
    BMJ. 2024;384:q527.
    

    >> Share

    
    February 2024
73. KMIETOWICZ Z
    Eating disorders: Targets fail to improve children's access to treatment, warn psychiatrists.
    BMJ. 2024;384:q523.
    

    >> Share

    
    January 2024
74. MYTTON OT, Head V, Reckless I
    Public health perspective on new weight loss medications.
    BMJ. 2024;384:q196.
    

    >> Share

    
    
75. MCNALLY S
    Scarlett McNally: Preventing obesity is different from curing it-and even more urgent.
    BMJ. 2024;384:q134.
    

    >> Share

    
    December 2023
76. COURCOULAS AP, Daigle CR, Arterburn DE
    Long term outcomes of metabolic/bariatric surgery in adults.
    BMJ. 2023;383:e071027.
    

    >> Share

    
    November 2023
77. IACOBUCCI G
    Challenges in diabetes and obesity: five minutes with . . . Jonathan Valabhji.
    BMJ. 2023;383:p2831.
    

    >> Share

    
    October 2023
78. LADHER N, Hinton R, Veitch E
    Challenges of obesity and type 2 diabetes require more attention to food environment.
    BMJ. 2023;383:p2269.
    

    >> Share

    
    
79. TOUVIER M, da Costa Louzada ML, Mozaffarian D, Baker P, et al
    Ultra-processed foods and cardiometabolic health: public health policies to reduce consumption cannot wait.
    BMJ. 2023;383:e075294.
    

    >> Share

    
    
80. GHOSH TS, Valdes AM
    Evidence for clinical interventions targeting the gut microbiome in cardiometabolic disease.
    BMJ. 2023;383:e075180.
    

    >> Share

    
    
81. MAESSEN SE, Nichols M, Cutfield W, Norris SA, et al
    High but decreasing prevalence of overweight in preschool children: encouragement for further action.
    BMJ. 2023;383:e075736.
    

    >> Share

    
    September 2023
82. KMIETOWICZ Z
    Endoscopic sleeve gastroplasty can be used to treat obesity, says NICE.
    BMJ. 2023;382:p2240.
    

    >> Share

    
    August 2023
83. MAHASE E
    Obesity: How long should drug treatment last?
    BMJ. 2023;382:p1772.
    

    >> Share

    
    June 2023
84. TANNE JH
    Obesity: Avoid using BMI alone when evaluating patients, say US doctors' leaders.
    BMJ. 2023;381:1400.
    

    >> Share

    
    
85. IACOBUCCI G
    NHS announces new specialist obesity clinics for children.
    BMJ. 2023;381:p1365.
    

    >> Share

    
    May 2023
86. MULRENAN C, Jenner K, Knai C
    Tackling the obesity epidemic.
    BMJ. 2023;381:p1072.
    

    >> Share

    
    
87. KMIETOWICZ Z
    Artificial sweeteners do not aid weight loss or improve health, says WHO.
    BMJ. 2023;381:p1112.
    

    >> Share

    
    April 2023
88. WATSON MC, Lloyd J
    Obesogenic environments: the UK government needs to act now.
    BMJ. 2023;381:p940.
    

    >> Share

    
    
89. KASSAM S
    Obesity: potatoes, pasta, and rice are not the problem.
    BMJ. 2023;381:p938.
    

    >> Share

    
    
90. MAHASE E
    Obesity: Politicians' fears over "nanny-statism" have contributed to failed strategies, says report.
    BMJ. 2023;381:p900.
    

    >> Share

    
    March 2023
91. WISE J
    Obesity conference ditches Nestle as sponsor after protests.
    BMJ. 2023;380:737.
    

    >> Share

    
    
92. 
    A call to the European Congress on Obesity: It's time to remove corporate sponsorship.
    BMJ. 2023;380:755.
    

    >> Share

    
    
93. MCNALLY S
    Scarlett McNally: Obesity is a community issue, not just an individual one.
    BMJ. 2023;380:702.
    

    >> Share

    
    
94. IACOBUCCI G
    Appetite suppressant semaglutide is to be made available to treat obesity in England.
    BMJ. 2023;380:p556.
    

    >> Share

    
    
95. MAHASE E
    Global cost of overweight and obesity will hit $4.32tn a year by 2035, report warns.
    BMJ. 2023;380:p523.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share